A cohort study published in JAMA Network Open determined that COVID vaccine uptake among immunocompromised individuals was low, implying that many people did not adhere to the CDC guidelines. According...
In a systematic review and meta-regression published in The Lancet Infectious Diseases, researchers determined that hybrid protection — the combination of SARS-CoV-2 infection and vaccination...
In a recent press release, the HIV Vaccine Trials Network (HVTN) announced that the Mosaico study, an investigational HIV vaccine study, was discontinued at phase 3 after an interim review by the Data...
In an article published in Cell Host and Microbe, NIH researchers — including Anthony Fauci, David Morens, and Jeffery Taubenberger — discuss necessary considerations for scientists to...
On December 8, 2022, Democratic Representative Rick Larsen introduced the Protecting America from Seasonal and Pandemic Influenza Act of 2022 — referred to as the Influenza Act. Backed by other representatives, clinicians, and public...
Early phase studies by scientists at the University of Washington found that a plasmid DNA breast cancer vaccine may produce favorable outcomes, generating anti-tumor immunity. The study, published in...
Throughout the COVID-19 pandemic, patients, researchers, and providers became increasingly familiar with mRNA vaccines, which have unparalleled public health benefits. While mRNA vaccines have been researched for years, the rapid...
Human immunodeficiency virus (HIV), a viral infection that attacks and weakens the immune system, impacts 38.4 million people worldwide. According to the WHO, in 2021, 650,000 people globally died of an HIV-related illness. Despite high...
Over the past few years, healthcare professionals and public health experts have seen the resurgence of many diseases that were once obsolete or nearly obsolete. In part, these rising rates have been...
Moderna Inc and Japan-based OriCiro Genomics K.K. reached an agreement on Wednesday wherein Moderna will acquire OriCiro and its suite of biopharmaceutical applications for $85...
Throughout the COVID-19 pandemic, the FDA has played a critical role in addressing public health concerns by encouraging practices to minimize infectious disease spread and expediting approval for...
As the COVID pandemic has progressed, the healthcare industry has seen the virus and the state of the pandemic evolve. Equipped with the available vaccines and treatments, providers and other...
As more and more providers warn against the tripledemic — including RSV, COVID, and influenza — it is crucial to understand the projections and impacts of these cases. Additionally, an in-depth understanding of the tools and...
The COVID-19 pandemic took the world by storm when it began in January 2020. Densely populated cities took a brutal hit with more significant percentages of infection, hospitalization, and death due to...
While less than ideal, the progression of the COVID-19 pandemic has presented public health officials with data to analyze on vaccine uptake. In a recent research letter published in JAMA Network Open,...
As the COVID-19 pandemic progresses, access and affordability to vaccines have been effective tools for public health professionals. Currently, the federal government covers COVID-19 vaccination...
After producing strong clinical trial results for its respiratory syncytial virus (RSV) vaccine, Pfizer says it is ending enrollment in its study and preparing to submit for FDA approval.
The Phase 3...
As with any vaccine, the COVID-19 vaccine led to some common side effects. However, the severity of these side effects varies by individual. In a recent study published in JAMA Network Open,...
The COVID-19 pandemic displayed the potential of a collaborative pharmaceutical industry. The worldwide cooperation between researchers, healthcare professionals, pharmaceutical companies, and industry leaders contributed to the now...
Gonorrhea is one of the most common bacterial infections and is the third most common sexually transmitted infection (STI) in the United States. In an effort to mitigate disease spread, the NIH’s...
